Grifols, S.A.
Grifols, S.A. (GIFOF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GIFOF · as of Jun 8, 2026
Key Statistics
Explore Grifols, S.A. Data
gifof stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 57.1%
Competitors & Peers
gifof competitorsGIFOF
ESAIY
ESALF
KYKOF
OPHLF
OPHLYStock Performance
Full HistoryAbout Grifols, S.A.
Grifols, S.A. is a Barcelona, Spain-based pharmaceutical company founded in 1940. The company primarily specializes in the acquisition, production, and distribution of therapeutic solutions, with a si…
what is grifols, s.a. · gifof stock overview · grifols, s.a. company profile · who is grifols, s.a. ceo · gifof OTC · grifols, s.a. headquarters · grifols, s.a. business segments
About Stock Overview & Key Data
Grifols, S.A. (GIFOF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Feb 6, 2013. As of the latest trading session, GIFOF stock price is $8.85, with a market capitalization of $8.7B. The stock has returned +7.27% over the past 12 months and +0.45% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Grifols, S.A. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Grifols, S.A. reported revenue of $7.5B and net income of $401.7M. For detailed data — including Grifols, S.A. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Grifols, S.A. (GIFOF) stock price is $8.85. The stock is traded on OTC under the ticker symbol GIFOF. The 52-week range is $8.20 – $8.85.